Erythropoietin (rHuEPO) has proven to be effective in the treatment of anemia of chronic renal failure (CRF). Despite improving the quality of life, peak oxygen uptake after rHuEPO therapy is not improved as much as the increase in hemoglobin concentration ([Hb)] would predict. We hypothesized that this discrepancy is due to failure of O2 transport rates to rise in a manner proportional to [Hb]. To test this, eight patients with CRF undergoing regular hemodialysis were studied pre-and post-rHuEPO ([Hb] = 7.5 +/-1.0 vs. 12.5 +/-1.0 g x dl-1) using a standard incremental cycle exercise protocol. A group of 12 healthy sedentary subjects of similar age and anthropometric characteristics served as controls. Arterial and femoral venous blood gas data were obtained and coupled with simultaneous measurements of femoral venous blood flow (Qleg) by thermodilution to obtain O2 delivery and oxygen uptake (VO2). Despite a 68% increase in [Hb], peak VO2 increased by only 33%. This could be explained largely by reduced peak leg blood flow, limiting the gain in O2 delivery to 37%. At peak VO2, after rHuEPO, O2 supply limitation of maximal VO2 was found to occur, permitting the calculation of a value for muscle O2 conductance from capillary to mitochondria (DO2). While DO2 was slightly improved after rHuEPO, it was only 67% of that of sedentary […] Research Article
Introduction
Anemia is a prominent complication of chronic renal failure (CRF) 1 that requires treatment in a significant number of patients undergoing hemodialysis (1, 2) . Since the late 80's, the therapy with recombinant human erythropoietin (rHuEPO) has effectively eliminated the need for red cell transfusions (1) (2) (3) (4) , thus avoiding commonly associated complications such as infections and iron overload. Patients receiving rHuEPO significantly improve their quality of life, but they exhibit a higher incidence of hypertension seemingly associated with the rHuEPO dosage (5) .
Physiological studies on the long-term cardiorespiratory effects of rHuEPO treatment suggest that the increase in hemoglobin concentration results in a suppression of the hyperdynamic cardiac state of these patients together with a modest improvement of the aerobic exercise performance (6) (7) (8) (9) (10) (11) (12) (13) . However, the effects of increased arterial O 2 content (CaO 2 ) on muscle O 2 use are not clear in CRF patients, and some of them fail to significantly improve aerobic exercise capacity after rHuEPO, despite near normalization of hemoglobin concentration ([Hb]) (14). This limited exercise response could be explained by one or more of the following factors: ( a ) gains in muscle O 2 delivery, calculated as the product of arterial O 2 content and muscle blood flow, could be less than expected; ( b ) muscle O 2 conductance from the muscle microcirculation to the mitochondria may be abnormally low, reducing the effect of increased O 2 delivery; or ( c ) oxygen uptake ( O 2 ) may not be O 2 supply limited, such that enzyme or substrate limitation would play the key role in determining O 2 max.
The current study was undertaken to assess the role of each of the above-mentioned mechanisms in eight sedentary young previously anemic, erythropoietin-treated patients with chronic renal failure undergoing regular hemodialysis. All performed maximum exercise on a bicycle ergometer at two different inspired O 2 concentrations (F I O 2 ), both before and after rHuEPO therapy to assess O 2 supply-dependence of peak O 2 . Data from 12 matched healthy young sedentary subjects from a previous study (15) following a similar protocol were used as control values. In all subjects, whole-body O 2 , O 2 V .
V .
V .
V . V . Table I . All were informed of any risks and discomfort associated with the experiment and informed consent was obtained in accordance with the Committee on Investigations Involving Human Subjects at the Hospital Clínic, Universitat de Barcelona. Subject preparation, safety precautions, and technical aspects of the central measurements (arterial and femoral venous blood gases and femoral venous blood flow) have been described in detail elsewhere (15, 18) .
Abbreviations used in this paper
Data from twelve healthy sedentary subjects, (11 males, 1 female) (age 22 Ϯ 3.2 y; height 174 Ϯ 8 cm; and wt 71 Ϯ 10 kg; hemoglobin concentration 13.8 g · dl
) selected on the basis of no previous history of regular or even occasional physical exercise above that required for average daily activities, were used as control values. These data have been previously reported (15) .
Preliminary measurements. Initially, each subject performed a standard noninvasive incremental cycle exercise test (20-Watt increments every 2 min) until exhaustion. This test, which was carried out breathing room air, served to determine maximal exercise capacity (cycloergometer; E. Jaeger, Würzburg, Germany).
Principal studies. On a single day, each renal failure patient performed two similar exercise tests to exhaustion. The only difference between each test was inspired O 2 concentration (F I O 2 ). This series of two tests was carried out twice, once before and once after rHuEPO. In the pre-rHuEPO study, the F I O 2 values were 0.21 in one test and 1.0 in the other, whereas in the post-rHuEPO study, the corresponding F I O 2 's were 0.13 and 0.21. The order of presentation of the 2 inspirates was randomized but was identical for each patient in the preand post-rHuEPO studies. Between the two exercise runs, the subject rested for fully 1 h to ensure an adequate recovery. A target workload for each test was defined as the maximum workload sustained for 2 min in the preliminary noninvasive study. However, an additional 20 W increment was tried to ensure that maximum exercise capacity had in fact been reached in each condition. The same level of daily physical activity (as before rHuEPO) was maintained throughout the period of the study despite the improvement in their quality of life, as assessed using a physical activity questionnaire. Pre-and post-rHuEPO studies in all the patients were done between 18 and 24 h after hemodialysis treatment (Table I) . The time elapsed between pre-and post-rHuEPO studies was 7 Ϯ 5 mo.
On-line calculations of whole body O 2 , CO 2 output ( CO 2 ), minute ventilation ( E ), respiratory exchange ratio (RER), heart rate, and respiratory rate were averaged sequentially over 15-s intervals and displayed on a screen monitor to observe the progress of the tests and confirm a steady state for O 2 . In each test, in the eight CRF patients in the pre-and post-rHuEPO studies, measurements were made under the following conditions: ( a ) at rest; ( b ) during submaximal workloads (30, 60 , and 80% of peak workload); and ( c ) at maximum workload. In the 12 healthy sedentary subjects measurements were done only: ( a ) at rest; ( b ) at 60% of maximum workload; and ( c ) at maximum workload (15 
Net lactate output across the leg ( ) was obtained as the product between leg and the femoral venous to arterial difference in blood lactate concentrations ( ϭ leg · (La fv Ϫ La a )]. In each subject, mea-
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La . Q . sured O 2 saturation and the corresponding PO 2 from all samples were used to estimate the P 50 of hemoglobin. Calculations of mean muscle capillary PO 2 (P mc O 2 ) and the corresponding value of muscle O 2 conductance (DO 2 ) were obtained by numerical integration (16, (19) (20) (21) (22) ; the assumptions involved in this analysis having been previously described in detail (16) . It should be noted that DO 2 is a lumped parameter that reflects both diffusional conductance and the effect of any heterogeneity of VO 2 with respect to blood flow. The O 2 conductance from the microcirculation to the muscle cell (DO 2 ) was calculated at peak exercise from: (a) the room air measurement in the prerHuEPO study; (b) the data of both the hypoxic and room air measurements (F I O 2 of 0.13 and 0.21) in the post-rHuEPO study; and (c) the data of both the hypoxic measurements (F I O 2 of 0.12 and 0.15) in the control group. Maximum O 2 uptake data breathing room air (control subjects) and 100% O 2 (pre-rHuEPO study) were not used to estimate DO 2 because they did not fulfill the requirements of the analysis, as discussed above and in (15) .
Data analysis. Results are expressed as meanϮSD. After rHuEPO, changes in leg were compared using an analysis of covariance after demonstrating existence of a linear relationship between leg and whole-body O 2 (as work rate was increased) with no variations in the slope from pre-to post-rHuEPO. For the remaining variables in the study, results during submaximal exercise were examined pooling the data obtained at 30, 60, and at 80% of peak work load. Comparisons between pre-and post-rHuEPO studies were done using the Student's paired t test, and those between post-rHuEPO and the control group of healthy sedentary subjects were carried out using the Student's unpaired t test. Pearson's regression analysis was used to Q .
V . Results expressed as meanϮSD; 30, 60, 80, and 100% W correspond to measurements carried out at those percentages of peak exercise workload; Pre-rHuEPO, Post-rHuEPO, and Control, results before rHuEPO therapy, Post-rHuEPO therapy, and from the sedentary control subjects respectively; O 2 , O 2 uptake; CO 2 , CO 2 production; RER, respiratory exchange ratio; E , minute ventilation (BTPS); HR, heart rate; pre-post, probability of the comparisons between pre-and post-rHuEPO measurements at peak exercise (paired analysis); post-con, probability of the comparisons between post-rHuEPO study and sedentary control subjects at peak exercise (unpaired analysis).
Figure 1.
Relationships between whole-body O 2 uptake and external work rate. pre-rHuEPO, prior to erythropoietin; post-rHuEPO, after erythropoietin therapy; control, healthy sedentary subjects. The calculated mechanical efficiency in the overall set of measurements was 26.8%. Results are expressed as meanϮSEM.
explore the relationships between variables. Statistical significance was set at P Յ 0.05.
Results
After the rHuEPO therapy, [Hb] in the eight renal patients increased by 5.0Ϯ1.8 g · dl
Ϫ1
, from 7.5Ϯ1.0-12.5Ϯ1.0 g · dl Ϫ1 (Table I). All patients had normal arterial blood gases both at rest and at all exercise workloads, as exemplified by the alveolararterial O 2 difference (at peak exercise, 5Ϯ8.3 and 3Ϯ9.0 mmHg, pre-and post-rHuEPO, respectively). Consequently, at rest, the 69% increase in [Hb] (mean of individual responses) after rHuEPO therapy resulted in a similar (59%) arterial O 2 content change of 6.2Ϯ2.4 ml O 2 · 100 ml Ϫ1 , from 10.8Ϯ1.6-17.0Ϯ1.4 ml O 2 · 100 ml
. Similar values were observed during exercise.
Exercise performance. Exercise data from the patients (pre-and post-rHuEPO) and from the sedentary control subjects are shown in Tables II and III and in Fig. 1-3 . Although a plateau in whole-body O 2 at peak workload could not be clearly defined in most of the patients, the respiratory exchange ratio (from 1.21 to 1.30) and the elevated blood lactate levels obtained at peak workload suggest that maximal exercise was achieved in both pre-and post-rHuEPO studies. After rHuEPO, peak whole-body O 2 increased 30% by 0.49Ϯ0.25 liters · min Ϫ1 but was still lower (P ϭ 0.03) than that observed in the control group (33.1Ϯ4.7 ml · kg Ϫ1 · min
, CRF postrHuEPO, and 36.9Ϯ5.9 ml · kg Ϫ1 · min
, normal subjects). As shown in Fig. 1 , the patients (pre-and post-rHuEPO) and the control subjects showed a similar linear relationship between whole-body VO 2 and external work.
After rHuEPO therapy (Fig. 2) , at any given oxygen uptake, E , RER, and femoral venous blood lactate levels (La fv ) were consistently lower. In the post-rHuEPO study, the relationships between these variables and whole-body O 2 were similar to those of sedentary control subjects, but maximal values of O 2 , E , and La fv were less than in control subjects. In contrast, at any given oxygen uptake, no significant changes were observed in the net lactate output across the leg between the patients (both pre-and post-rHuEPO) and the control group.
One-leg blood flow and O 2 delivery. Femoral venous blood flow ( leg) was consistently reduced after rHuEPO (P Ͻ 0.004). On average, leg decreased by 0.70Ϯ0.9 liters · min ( Fig. 3 and Table III ), a fall of 13% at peak exercise compared to before rHuEPO. This reduction in leg partially offset the effect of the rHuEPO-induced increase in arterial O 2 content of O 2 delivery ( O 2 leg). Consequently, the increase in O 2 leg after rHuEPO at peak exercise was only 0.22Ϯ0.25 liters · min Ϫ1 (37%). One-leg O 2 uptake. As shown in Table III , leg O 2 significantly increased after rHuEPO at each relative workload (P ϭ 0.05). This was because a given relative work load occurred at a higher absolute level post-rHuEPO. At peak exercise, postrHuEPO O 2 leg rose by 0.13Ϯ0.13 liters · min Ϫ1 (33%) (P ϭ Q .
0.03) but was still 18% lower than that observed in the control group (8.5Ϯ1.6 compared to 10Ϯ2.7 ml · kg Ϫ1 · min
, respectively).
Femoral venous PO 2 and O 2 extraction. At peak exercise, no significant changes were observed in femoral venous PO 2 (P fv O 2 ) (24Ϯ2.7 mmHg pre-rHuEPO vs. 27Ϯ5.4 mmHg post rHuEPO), femoral venous O 2 saturation (28.6Ϯ6.8 vs. 27.9Ϯ9.0%) or in O 2 extraction ratio (O 2 ER) at peak exercise after rHuEPO (from 71Ϯ6 to 70Ϯ10%, respectively). PostrHuEPO O 2 ER was similar to that observed in the control group (72Ϯ8%). uptake; , lactate output across the leg; pre-post, probability of the comparisons between pre-and post-rHuEPO measurements at peak exercise (paired analysis); post-con, probability of the comparisons between post-rHuEPO study and sedentary control subjects at peak exercise (unpaired analysis).
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DO 2 at peak exercise. In the post-rHuEPO study, O 2 leg and mean muscle capillary PO 2 (or femoral venous PO 2 ) at maximum exercise determined during hypoxia and room air followed a linear and proportional relationship. Hence, O 2 supply dependency of peak O 2 constitutes a reasonable assumption, allowing calculation of O 2 conductance, as analyzed in Discussion. Such behavior was also observed in the studies during hypoxia in the control group (15) . The slopes of the dashed lines in Fig. 4 
Discussion
Summary of principal findings. This study shows that after erythropoietin therapy there is a substantial rise (69%) in hemoglobin concentration, and thus in CaO 2 (59%) in patients with chronic renal failure, but at the same time a moderate but consistent fall in femoral venous blood flow (of 13% at peak O 2 and even more submaximally) (Fig. 3) . The latter is probably due to the reversal of the hyperhemodynamic state provoked by the anemia (23, 24) . The fall in leg partially offset the increase in O 2 delivery expected from the rise in arterial O 2 content. Thus, O 2 leg rose by only 37%.
While rHuEPO enhanced aerobic capacity (whole-body O 2 by 30% and O 2 leg by 33%, respectively) (Figs. 2 and 3 ), the relative change was much less than that of arterial O 2 content (59%). This occurred despite increases in the two major components of O 2 transport from the atmosphere to the muscle cell after rHuEPO: oxygen delivery (37%) and muscle O 2 conductance (31%). The relative contributions of these two components of O 2 transport can explain the differences between the gains in O 2 content and O 2 leg at peak exercise, as discussed below.
Oxygen supply limitation of peak O 2 was found to occur after rHuEPO, as indicated in Fig. 4 and discussed below, which allowed an estimate of muscle O 2 conductance. It should be noted that although DO 2 increased 31% with erythropoietin, post-rHuEPO DO 2 was the most severely impaired index of O 2 transport (Fig. 5) , being 33% less than that in activitymatched control subjects.
Since 1990, several studies (5-13) have shown a rather small improvement in O 2 peak after rHuEPO therapy despite increases in [Hb] to almost normal levels, as confirmed in the present study. Impairment of O 2 transport to the mitochondria and/or alterations in the regulation of the oxidative phosphorylation in the cell have been invoked as the two potential explanations of the phenomenon, but no measurements have been made to confirm or refute these suggestions. The current study therefore represents the first integrative investigation of the changes with rHuEPO in the factors determining muscle O 2 transport. Recently, Moore et al. (25) reported no differences in cellular oxidative capacity (31-phosphorus nuclear magnetic resonance spectroscopy) among: (a) CRF patients under regular hemodialysis; (b) patients after renal transplantation; and (c) control subjects, indirectly suggesting impairment in O 2 transport in the muscle microcirculation as the primary explanation for the limited increase in O 2 peak after rHuEPO. Dissociation between systemic hematocrit and microvascular hematocrit (26) can be invoked as an additional factor to explain the differences between gains in CaO 2 and in O 2 leg at peak exercise after rHuEPO therapy. However, this possibility could not be ruled out since microvascular hematocrit cannot be measured during exercise in intact subjects. Muscle biopsies done in CRF patients (27) indicate that many muscle fibers show abnormally low adjacent capillary supply, which would provide the structural bases for the low muscle O 2 conductance obtained in our study. The results from the current investigation support the contention that abnormal muscle O 2 transport is the key factor limiting increases in O 2 in anemic CRF patients after rHuEPO therapy.
Interactions between O 2 delivery and muscle O 2 conductance in the effects of rHuEPO. As proposed by Piiper and Scheid (28) , O 2 extraction (under conditions of O 2 supply limitation of O 2 max) depends on the ratio of muscle O 2 diffusional conductance (DO 2 ) to perfusional conductance (␤ · leg). The term ␤ corresponds to the slope of the O 2 dissociation curve and is the ratio of the arterial to femoral venous O 2 content difference and the arterial to femoral venous PO 2 
The most efficient way to improve O 2 transfer to the mitochondria therefore occurs in those circumstances that provide an increase in this ratio. Endurance training for example, increases not only cardiac function, and thus leg, but also DO 2 . Because DO 2 increases relatively more than does leg (15), DO 2 /␤ · leg increases, raising maximal O 2 extraction. Thus O 2 max increases with training due to both increased leg blood flow and increased O 2 extraction (15).
In contrast, the patients with chronic renal failure of the present study showed a fall in leg (13%), an increase in DO 2 (31%), and an increase in [Hb] (69%) that raised ␤ by 65%. This led to no significant change in DO 2 /␤ · leg ratio (2.22Ϯ 0.70 pre-rHuEPO vs. 2.12Ϯ0.58 post-rHuEPO) explaining how after rHuEPO, CRF patients do not exhibit any change in muscle O 2 extraction. Had DO 2 not increased by 31%, DO 2 /␤ · leg would have fallen to ‫ف‬ 1.7 and O 2 extraction would have fallen, further reducing the benefits of rHuEPO on O 2 peak. DO 2 probably increased due to the higher [Hb], consistent with previous observations (29) , although the specific mechanism remains obscure.
Analysis of O 2 supply limitation. The use of two levels of F I O 2 in the pre-and post-rHuEPO studies was adopted because the calculation of DO 2 requires the demonstration of O 2 supply dependence of peak O 2 (16, 19, 21) , and changing V .
V . (15) , such that the relative increase in DO 2 after rHuEPO would be overestimated.
As indicated in Fig. 4 , conditions of O 2 supply dependency were satisfied in the post-rHuEPO study and in the hypoxic measurements carried out in the control group. O 2 peak increased with F I O 2 in an amount that reflects the corresponding increase in O 2 delivery. However, the CRF patients were not tested in the pre-rHuEPO study since the estimation of muscle O 2 conductance was done only during room air breathing. It should be noted that the arterial O 2 content before rHuEPO at F I O 2 ϭ 0.21 was similar to that observed post-rHuEPO at an FIO 2 of 0.13 and in the healthy sedentary subjects at F I O 2 ϭ 0.12. Consequently, it can be reasonably argued that the CRF patients were likely to be O 2 supply dependent breathing room air in the pre-rHuEPO study. However, if anything, prerHuEPO O 2 conductance at F I O 2 ϭ 0.21 would have been underestimated if peak O 2 breathing air were not O 2 supply limited (15) , so that the calculated 31% change in DO 2 is a maximal value. It should be noted that up to 71% of the variance in DO 2 (calculated assuming O 2 supply dependence) was explained by the concomitant changes in both hemoglobin concentration and femoral venous flow.
Comparisons between the post-rHuEPO study and the control group (Fig. 5) . Hemoglobin concentration and leg at peak exercise after rHuEPO were slightly lower than in the healthy sedentary subjects (Ϫ9 and Ϫ4%, respectively). No such difference was observed in arterial PO 2 , and consequently the O 2 leg was 15% lower in the patients with CRF. However, muscle O 2 conductance, among all variables determining O 2 transport, was the most severely impaired in the CRF patients. Even after rHuEPO, DO 2 was 33% lower than that of the control group, which was well matched for lack of exercise and for age, height, and weight. The higher O 2 delivery (15%) and the higher DO 2 /␤ · leg ratio (8%) observed in the healthy sedentary subjects together explain the higher O 2 leg at maximum exercise (by 18%) of the control group compared to the post-rHuEPO CRF patients.
The structural basis for the reduced muscle O 2 conductance was not examined in the present study since muscle biopsies were not attempted, but it is likely to reflect a less rich muscle microcirculatory network (27, 30, 31) , since a previous study in a dog model without renal disease (32) has highlighted capillary surface area in muscle as the key structural factor that determines O 2 conductance. In contrast, the subsequent diffusion distance to the mitochondria appears to offer little impediment V .
V .
Q .
to O 2 transport, presumably due to diffusion facilitation by myoglobin (33) . The structural heterogeneity in the matching of capillaries to muscle fibers observed in CRF patients (27) suggests that functional heterogeneity of / O 2 ratios may constitute an additional factor to explain impairment of muscle O 2 transfer in these patients. Although limitation of aerobic capacity in CRF patients is a complex phenomenon, the present study provides the first direct evidence for impaired O 2 transport out of the muscle microcirculation. This may explain, in part, the subnormal levels of O 2 peak in chronic renal failure and the poor response to rHuEPO. Possible exercise training during rHuEPO therapy. In the current study, to preclude training occurring as a result of feeling better after rHuEPO therapy, all CRF patients were repeatedly instructed to maintain the same level of daily physical activity throughout the protocol. However, if any spontaneous training effect had developed as a result of the improvement of both quality of life and exercise tolerance, the end result would have presumably been an increase in leg and muscle O 2 conductance. Thus, this would have decreased the differences between post-rHuEPO measurements and those obtained in the sedentary control subjects. Consequently, the assertion of an abnormally low O 2 conductance even after [Hb] restoration is, if anything, strengthened to the extent that any training took place without our knowledge.
In summary, the hemodynamic response of reduced leg blood flow to the increase in hemoglobin concentration produced by rHuEPO plays a key role in limiting the increase in O 2 uptake at peak exercise. Analysis of the interactions between the convective and diffusive components of muscle O 2 transport shows an increased but still abnormally low muscle O 2 conductance after rHuEPO. However, the even greater net increase in perfusional conductance for O 2 due to the increase in [Hb] contributes to the relatively limited increase in peak O 2 because it does not allow O 2 extraction to increase. Muscle O 2 transport conductance in CRF, even after rHuEPO, is ‫ف‬ 33% lower than that in control subjects (matched for age, size, and activity). This suggests a myopathic alteration, possibly of the microcirculation, due to renal failure that compromises exercise capacity more than anemia and inactivity alone would predict.
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